Shopping Cart 0
Cart Subtotal
USD 0

Quidel Corp (QDEL) - Medical Equipment - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Quidel Corp (Quidel) develops, manufactures and markets rapid diagnostic testing solutions for the detection and diagnosis of critical diseases and other medical conditions. Its major products include immunoassays; molecular assays; virology products including traditional cell lines, specimen collection devices, media and controls; and specialty products including metabolic bone markers and enzyme linked immunosorbent assays (ELISA) and reagents. The company offers its products to physician offices, hospitals, clinical and reference laboratories, universities, retail clinics, pharmacies and wellness screening centers. Quidel distributes its products through direct sales force and a network of national and regional distributors. It has a direct presence in the US and Germany. Quidel is headquartered in San Diego, California, the US.

Quidel Corp (QDEL)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Quidel Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Quidel Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Quidel Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Quidel Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 8

Quidel Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Quidel Corp, Medical Equipment, Deal Details 10

Asset Purchase 10

Quidel Acquires Triage and BNP Business from Alere 10

Quidel Acquires InflammaDry and AdenoPlus Diagnostic Businesses from Rapid Pathogen Screening for USD14 Million 12

Partnerships 13

InGen BioSciences Enters Into Distribution Agreement With Quidel 13

InGen BioSciences Enters Into Distribution Agreement With Diagnostic Hybrids 14

Debt Offering 15

Quidel Raises USD172.5 Million in Public Offering of 3.25% Senior Notes Due 2020 15

Acquisition 17

Quidel Acquires AnDiaTec 17

Quidel Acquires BioHelix, Molecular Diagnostic Company, For USD 10 Million 18

Quidel Corp-Key Competitors 19

Quidel Corp-Key Employees 20

Quidel Corp-Locations And Subsidiaries 21

Head Office 21

Other Locations & Subsidiaries 21

Recent Developments 22

Financial Announcements 22

Aug 07, 2018: Quidel reports second quarter 2018 financial results 22

May 08, 2018: Quidel Announces First Quarter 2018 Financial Results 24

Feb 21, 2018: Quidel Reports Fourth Quarter and Full Year 2017 Financial Results 26

Nov 01, 2017: Quidel Reports Third Quarter 2017 Financial Results 28

Jul 26, 2017: Quidel Reports Second Quarter 2017 Financial Results 30

Apr 24, 2017: Quidel Reports First Quarter 2017 Financial Results 32

Feb 08, 2017: Quidel Reports Fourth Quarter and Full Year 2016 Financial Results 33

Jan 06, 2017: Quidel Announces Preliminary Revenue for Fourth Quarter 2016 35

Other Significant Developments 36

Feb 19, 2018: Quidel to establish new Business Service Centre in Galway city 36

Nov 27, 2017: Quidel Confident in Legal Strength and Validity of Supply Agreement with Beckman Coulter to Sell BNP Assay Assets 37

Jan 23, 2017: Quidel Announces Modification of Revenue Reporting Categories 38

Appendix 39

Methodology 39

About GlobalData 39

Contact Us 39

Disclaimer 39


List Of Figure

List of Figures

Quidel Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Quidel Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Quidel Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Quidel Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Quidel Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Quidel Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 6

Quidel Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Quidel Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 8


List Of Table

List of Tables

Quidel Corp, Medical Equipment, Key Facts, 2017 2

Quidel Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Quidel Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Quidel Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Quidel Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Quidel Corp, Deals By Market, 2012 to YTD 2018 8

Quidel Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Quidel Acquires Triage and BNP Business from Alere 10

Quidel Acquires InflammaDry and AdenoPlus Diagnostic Businesses from Rapid Pathogen Screening for USD14 Million 12

InGen BioSciences Enters Into Distribution Agreement With Quidel 13

InGen BioSciences Enters Into Distribution Agreement With Diagnostic Hybrids 14

Quidel Raises USD172.5 Million in Public Offering of 3.25% Senior Notes Due 2020 15

Quidel Acquires AnDiaTec 17

Quidel Acquires BioHelix, Molecular Diagnostic Company, For USD 10 Million 18

Quidel Corp, Key Competitors 19

Quidel Corp, Key Employees 20

Quidel Corp, Other Locations 21

Quidel Corp, Subsidiaries 21

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Quidel Corp, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Summary

Quidel Corp (Quidel) develops, manufactures and markets rapid diagnostic testing solutions for the detection and diagnosis of critical diseases and other medical conditions. Its major products include immunoassays; molecular assays; virology products including traditional cell lines, specimen collection devices, media and controls; and specialty products including metabolic bone markers and enzyme linked immunosorbent assays (ELISA) and reagents. The company offers its products to physician offices, hospitals, clinical and reference laboratories, universities, retail clinics, pharmacies and wellness screening centers. Quidel distributes its products through direct sales force and a network of national and regional distributors. It has a direct presence in the US and Germany. Quidel is headquartered in San Diego, California, the US.

Quidel Corp (QDEL)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Quidel Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Quidel Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Quidel Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Quidel Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 8

Quidel Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Quidel Corp, Medical Equipment, Deal Details 10

Asset Purchase 10

Quidel Acquires Triage and BNP Business from Alere 10

Quidel Acquires InflammaDry and AdenoPlus Diagnostic Businesses from Rapid Pathogen Screening for USD14 Million 12

Partnerships 13

InGen BioSciences Enters Into Distribution Agreement With Quidel 13

InGen BioSciences Enters Into Distribution Agreement With Diagnostic Hybrids 14

Debt Offering 15

Quidel Raises USD172.5 Million in Public Offering of 3.25% Senior Notes Due 2020 15

Acquisition 17

Quidel Acquires AnDiaTec 17

Quidel Acquires BioHelix, Molecular Diagnostic Company, For USD 10 Million 18

Quidel Corp-Key Competitors 19

Quidel Corp-Key Employees 20

Quidel Corp-Locations And Subsidiaries 21

Head Office 21

Other Locations & Subsidiaries 21

Recent Developments 22

Financial Announcements 22

Aug 07, 2018: Quidel reports second quarter 2018 financial results 22

May 08, 2018: Quidel Announces First Quarter 2018 Financial Results 24

Feb 21, 2018: Quidel Reports Fourth Quarter and Full Year 2017 Financial Results 26

Nov 01, 2017: Quidel Reports Third Quarter 2017 Financial Results 28

Jul 26, 2017: Quidel Reports Second Quarter 2017 Financial Results 30

Apr 24, 2017: Quidel Reports First Quarter 2017 Financial Results 32

Feb 08, 2017: Quidel Reports Fourth Quarter and Full Year 2016 Financial Results 33

Jan 06, 2017: Quidel Announces Preliminary Revenue for Fourth Quarter 2016 35

Other Significant Developments 36

Feb 19, 2018: Quidel to establish new Business Service Centre in Galway city 36

Nov 27, 2017: Quidel Confident in Legal Strength and Validity of Supply Agreement with Beckman Coulter to Sell BNP Assay Assets 37

Jan 23, 2017: Quidel Announces Modification of Revenue Reporting Categories 38

Appendix 39

Methodology 39

About GlobalData 39

Contact Us 39

Disclaimer 39


List Of Figure

List of Figures

Quidel Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Quidel Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Quidel Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Quidel Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Quidel Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Quidel Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 6

Quidel Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Quidel Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 8


List Of Table

List of Tables

Quidel Corp, Medical Equipment, Key Facts, 2017 2

Quidel Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Quidel Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Quidel Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Quidel Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Quidel Corp, Deals By Market, 2012 to YTD 2018 8

Quidel Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Quidel Acquires Triage and BNP Business from Alere 10

Quidel Acquires InflammaDry and AdenoPlus Diagnostic Businesses from Rapid Pathogen Screening for USD14 Million 12

InGen BioSciences Enters Into Distribution Agreement With Quidel 13

InGen BioSciences Enters Into Distribution Agreement With Diagnostic Hybrids 14

Quidel Raises USD172.5 Million in Public Offering of 3.25% Senior Notes Due 2020 15

Quidel Acquires AnDiaTec 17

Quidel Acquires BioHelix, Molecular Diagnostic Company, For USD 10 Million 18

Quidel Corp, Key Competitors 19

Quidel Corp, Key Employees 20

Quidel Corp, Other Locations 21

Quidel Corp, Subsidiaries 21

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Quidel Corp, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.